Paasa Logo
Black Diamond Therapeutics, Inc. logo
BDTXNASDAQMarket openCloses 4:00pm ET

Black Diamond Therapeutics, Inc.

$1.88Last updated
+$0.05 (2.73%)Past day
Timezone

Black Diamond Therapeutics, Inc. (NASDAQ: BDTX) is trading at $1.88, about ₹181 at today's USD/INR rate, as of 29 Sep 2026, 2:02 PM ET, up 2.73% today. Indian residents can buy Black Diamond Therapeutics from India on Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:$1.84
Previous close:$1.83
Volume:271.17K

Today's low

$1.84

Today's high

$1.88

52 week low

$1.60

52 week high

$4.94

BDTX opened at $1.84, closed previously at $1.83, and has traded between $1.60 and $4.94 over the past 52 weeks.

About

Black Diamond Therapeutics, Inc. is a biotechnology enterprise dedicated to discovering, advancing, and bringing to market therapeutic agents specifically designed for patients with genetically characterized tumors. A core part of its pipeline is BDTX-189, an irreversible small molecule inhibitor. This compound is engineered to neutralize oncogenic proteins driven by non-canonical epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2) driver mutations. The firm is also progressing BDTX-1535, a brain-penetrant inhibitor addressing a range of EGFR mutations, including conventional, inherent resistance, and acquired resistance forms. Concurrently, it is advancing BDTX-4933, another brain-penetrant inhibitor targeting oncogenic BRAF alterations across Class I, II, and III categories. Black Diamond maintains a strategic alliance with OpenEye Scientific Software, Inc. Established in 2014, the company was initially known as ASET Therapeutics, Inc. before adopting its current name, Black Diamond Therapeutics, Inc., in January 2018. Its corporate headquarters are situated in Cambridge, Massachusetts.

Country
US
CEO
Mark A. Velleca
Exchange listed on
NASDAQ
Industry
Biotechnology
Base currency
USD
Full Time Employees
21
Sector
Healthcare
IPO date
31/01/2020

Key statistics

Avg. volume

1.36M

Market cap

$107.73M

P/E Ratio

-2.54

Price-to-sales ratio

0.00

Enterprise value

$135.98M

Free cash flow yield

21.43%

Debt-to-equity ratio

0.18

Return on equity

19.93%

ROIC

15.17%

Beta

3.31

Dividend yield

0.00%

Last dividend

$0.00

Financial overview

Revenue

$70.00M

Earnings per share

$0.39

Free cash flow

$29.61M

Net profit margin

0.00%

Gross margin

0.00%

EBITDA

$22.69M

Revenue growth

0.00%

Similar securities

This is not an investment recommendation

How to buy Black Diamond Therapeutics from India

Indian residents can buy Black Diamond Therapeutics shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.

  1. Open a Paasa account

    Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds under LRS

    Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.

  3. Search for Black Diamond Therapeutics and place an order

    Find Black Diamond Therapeutics by name or by its ticker, BDTX, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. Black Diamond Therapeutics trades 7:00 pm – 1:30 am IST; orders can only execute during that window.

  4. Track holdings and download tax reports

    Follow your Black Diamond Therapeutics position in USD and INR. Black Diamond Therapeutics pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.

Read the full guide: how to invest in Black Diamond Therapeutics from India

Trading and taxes when buying Black Diamond Therapeutics from India

Trading and limits

Trading hours
9:30 am – 4:00 pm ET
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
NoneBlack Diamond Therapeutics does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
US estate tax
May applyUS-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons.US estate tax calculator

Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

FAQs

Can Indian residents buy Black Diamond Therapeutics stock?

Yes. Black Diamond Therapeutics (BDTX) has been listed on NASDAQ since 2020, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

How much does one Black Diamond Therapeutics share cost in rupees?

One Black Diamond Therapeutics share is $1.88 — about ₹181 at a USD/INR rate of 96.07 on 28 Sep 2026. Both the Black Diamond Therapeutics price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for buying Black Diamond Therapeutics from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.

Can I buy whole shares of Black Diamond Therapeutics?

Yes. One Black Diamond Therapeutics share is $1.88, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in Black Diamond Therapeutics.

How are gains on Black Diamond Therapeutics shares taxed in India?

The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Black Diamond Therapeutics price. Paasa issues a capital-gains statement for your return.

Does Black Diamond Therapeutics pay a dividend?

No. Black Diamond Therapeutics does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.

When can I trade Black Diamond Therapeutics from India?

NASDAQ trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.

Is there estate or inheritance tax on Black Diamond Therapeutics shares held from India?

US-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons. It applies to your overall holdings in that jurisdiction rather than to any one position. Paasa's US estate tax calculator shows the exposure for a given portfolio value.

Do I have to declare Black Diamond Therapeutics shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Black Diamond Therapeutics holding, its cost and its closing value.

How do I sell Black Diamond Therapeutics and bring the money back to India?

You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.